Dorcas Kamuya

A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK Gathuri H Mwaniki P Orindi B Otieno EO Mwakio S Mulemi L Isaaka L Shangala J Saisi M Isinde E Oginga IN Wachira AW Manuthu E Kariuki H Asaava P Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi DM Lusamba W Muthui B Adembesa I Mithi C Sood M Aliyan NA Gituma B Matiko MG Omondi CA Ombajo LA Kirui N Ochola L Abdi AI Kagucia EW English M Hamaluba M Ochola-Oyier I Kamuya D Bejon P Barasa E Agweyu A Akech S Etyang AO
N Engl J Med, (2025). 393:2187-2197

A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA).Lucinde R Abdi A Orindi B Mwakio S Gathuri H Onyango E Chira S Ogero M Isaaka L Shangala J Oginga IN Wachira A Manuthu E Kariuki H Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi D Lusamba W Muthui B Kirui N Adembesa I Mithi C Sood M Ahmed N Gituma B Ongaki VB Giabe M Omondi C Ombajo LA Kagucia W English M Hamaluba M Ochola-Oyier LI Kamuya D Bejon P Agweyu A Akech S Etyang AO
Wellcome Open Res, (2025). 7:269

COVID-19 mortality in Africa and Asia - Authors' reply.Bejon P Agweyu A Oyier I Hamaluba M Kamuya D Kinyanjui S Barasa E
Lancet Infect Dis, (2025). 25:e440

Creating different global health futures: mapping the health research ecosystem and taking decolonial action.Tagoe N Abimbola S Bilardi D Kamuya D Gilson L Muraya K Molyneux S Atuire C
BMC Health Serv Res, (2025). 25:565

Rethinking the evidence on COVID-19 in Africa.Bejon P Agweyu A Ochola-Oyier LI Hamaluba M Kamuya D Kinyanjui S Barasa E
Lancet Infect Dis, (2025). 25:e463-e471

Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice.Gobat N Slack C Hannah S Salzwedel J Bladon G Burgos JG Purvis B Molony-Oates B Siegfried N Cheah PY Conway M Kamuya D Davies A Johnson T Tholanah M Mugamba S Mutengu NL Machingaidze S Schwartz L Rago L von Harbou K
Lancet Glob Health, (2025). 13:e716-e731

Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study.Hinga A Ibrahim A Vintimilla D Jones M Eckstein L Rid A Shah SK Kamuya D
BMJ Glob Health, (2024). 9:

A scoping review of ethics review processes during public health emergencies in Africa.Orievulu K Hinga A Nkosi B Ngwenya N Seeley J Akanlu A Tindana P Molyneux S Kinyanjui S Kamuya D
BMC Med Ethics, (2024). 25:63

Community engagement and the centrality of 'working relationships' in health research.Vincent R Kamuya D Adhikari B Nyirenda D Lavery JV Molyneux S
BMJ Glob Health, (2024). 9:

Ethical issues of involving people with intellectual disabilities in genomic research: a scoping review protocol.Chepkirui D Kipkemoi P Bitta M Harris E Musesengwa R Kamuya D
Wellcome Open Res, (2023). 8:340

The hidden emotional labour behind ensuring the social value of research: Experiences of frontline health policy and systems researchers based in Kenya during COVID-19.Nzinga J Oliwa J Oluoch D Jepkosgei J Mbuthia D Boga M Musitia P Ogola M Muinga N Muraya K Hinga A Kamuya D Kelley M Molyneux S
PLOS Glob Public Health, (2023). 3:e0002116

A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses.Ngwenya N Ilo Van Nuil J Nyirenda D Chambers M Cheah PY Seeley J Chi P Mafuleka L Nkosi B Kamuya D Davies A Schneiders ML Mumba N Dlamini S Desmond N Marsh V Rippon D Parker M Molyneux S
Wellcome Open Res, (2023). 7:48

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.Odera DO Tuju J Mwai K Nkumama IN Furle K Chege T Kimathi R Diehl S Musasia FK Rosenkranz M Njuguna P Hamaluba M Kapulu MC Frank R Chmi-Sika Study Team Osier FHA Abdi AI Chi PC de Laurent Z Jao I Kamuya D Kamuyu G Makale J Murungi L Musyoki J Muthui M Mwacharo J Kariuki S Mwanga D Mwongeli J Ndungu F Njue M Nyangweso G Kimani D Ngoi JM Musembi J Ngoto O Otieno E Ooko M Shangala J Wambua J Mohammed KS Omuoyo D Mosobo M Kibinge N Kinyanjui S Bejon P Lowe B Marsh K Marsh V Abebe Y Billingsley PF Sim BKL Hoffman SL James ER Richie TL Audi A Olewe F Oloo J Ongecha J Ongas MO Koskei N Bull PC Hodgson SH Kivisi C Imwong M Murphy SC Ogutu B Tarning J Winterberg M Williams TN
Sci Transl Med, (2023). 15:eabn5993

Rethinking benefit sharing in collaborative human genetic research from an Afrocommunitarian perspective.Ewuoso C Sudoi A Kamuya D
Front Genet, (2022). 13:1014120

Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.Mumba N Njuguna P Chi P Marsh V Awuor E Hamaluba M Mauncho C Mwalukore S Masha J Mwangoma M Kalama B Alphan H Wambua J Bejon P Kamuya D Kapulu MC
Front Public Health, (2022). 10:793913

Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.Chi PC Owino EA Jao I Bejon P Kapulu M Marsh V Kamuya D
BMC Med Ethics, (2022). 23:46

Strengthening the Health System as a Strategy to Achieving a Universal Health Coverage in Underprivileged Communities in Africa: A Scoping Review.Jaca A Malinga T Iwu-Jaja CJ Nnaji CA Okeibunor JC Kamuya D Wiysonge CS
Int J Environ Res Public Health, (2022). 19:

A scoping review of considerations and practices for benefit sharing in biobanking.Sudoi A De Vries J Kamuya D
BMC Med Ethics, (2021). 22:102

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.Chi PC Owino EA Jao I Olewe F Ogutu B Bejon P Kapulu M Kamuya D Marsh V Chmi-Sika Study Team
Trials, (2021). 22:494

Always leave the audience wanting more: An entertaining approach to stimulate engagement with health research among publics in coastal Kenya through 'Magnet Theatre'.Sanga G Jao I Mumba N Mwalukore S Kamuya D Davies A
Wellcome Open Res, (2021). 6:2